Angina Market Report 2026
Download Free Sample Buy Now
Angina Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Angina Market Report 2026

Global Outlook – By Type (Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types), By Treatment (Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments), By Drug Class (Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes), By Application (Clinics, Hospitals, Other Applications) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Angina Market Overview

• Angina market size has reached to $11.36 billion in 2025

• Expected to grow to $14.84 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%

• Growth Driver: Rising Prevalence of Cardiovascular Diseases Driving The Market Growth Due To Increased Demand for Angina Treatments

• Market Trend: Pharmaceutical Companies Innovate With Metoprolol Tartrate Tablets To Enhance Treatment For Coronary Artery Disease And Related Conditions

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Angina Market?

Angina, also known as angina pectoris, is a medical condition characterized by chest pain or discomfort, typically caused by insufficient blood flow to the heart muscle. It inadequate blood flow is usually a result of blockages or narrowing of the coronary arteries due to atherosclerosis.

The main types of angina are angina pectoris, unstable angina, prinzmetal angina, and others. Angina pectoris, a medical condition associated with coronary heart disease, manifests as chest discomfort or pain due to insufficient blood supply to the heart, often attributed to blockages in the heart's arteries. The different types of treatment include lifestyle changes, medications, angioplasty and stenting, coronary bypass surgery, others with various drug classes such as beta-blockers, nitrates, and calcium channel blockers, angiotensin-converting enzyme inhibitors, others that are used in multiple applications such as clinics, hospitals, and others.

Angina Market Global Report 2026 Market Report bar graph

What Is The Angina Market Size and Share 2026?

The angina market size has grown strongly in recent years. It will grow from $11.36 billion in 2025 to $12.05 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, availability of beta blockers and nitrates, expansion of hospital cardiac care units, increased diagnostic testing, growth of cardiology specialty care.

What Is The Angina Market Growth Forecast?

The angina market size is expected to see strong growth in the next few years. It will grow to $14.84 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to growing demand for personalized cardiovascular treatment, increasing use of minimally invasive cardiac procedures, rising adoption of digital cardiac monitoring, expansion of preventive cardiology programs, advancements in cardiovascular drug development. Major trends in the forecast period include increasing adoption of combination drug therapies, rising use of long-acting nitrates, growing focus on preventive cardiac care, expansion of interventional treatment options, enhanced emphasis on lifestyle and risk management.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Angina Market Segmentation

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

What Is The Driver Of The Angina Market?

The rising prevalence of cardiovascular diseases is expected to propel the growth of the angina market going forward. Cardiovascular diseases are disorders of the heart and blood vessels that include conditions such as coronary heart disease, heart failure, and stroke. The growing prevalence of cardiovascular diseases is largely driven by aging populations and increased exposure to modifiable risk factors such as poor diet, physical inactivity, and tobacco use. The rising prevalence of cardiovascular diseases boosts demand for angina treatments, as these conditions frequently manifest with chest pain requiring medical management to reduce symptoms and prevent complications. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency that monitors public health, cardiovascular disease deaths increased from 371,506 cases in 2022 to 919,032 deaths in 2023. Therefore, the rising prevalence of cardiovascular diseases is driving the growth of the angina industry.

Key Players In The Global Angina Market

Major companies operating in the angina market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd

Global Angina Market Trends and Insights

Major companies operating in the angina market are developing innovative drugs such as metoprolol tartrate tablets to provide more effective and targeted treatments for patients who have coronary artery disease (CAD) and related conditions. Metoprolol tartrate tablets are a form of medication commonly used to treat various cardiovascular conditions, including angina (chest pain), hypertension (high blood pressure), and heart failure. For instance, in April 2023, Zydus, an India-based pharmaceutical company, received final approval from the United States Food and Drug Administration (US-FDA) to manufacture and market its generic version of Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg. Metoprolol is a beta blocker used to treat various cardiovascular conditions, including high blood pressure (hypertension) and chest pain (angina), and to improve survival after a heart attack.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Angina Market?

In March 2024, Novo Nordisk, a Denmark-based healthcare company, acquired Cardior Pharmaceuticals for $1.10 billion(€1.025 billion). This acquisition aims to strengthen Novo Nordisk's pipeline in cardiovascular disease management by incorporating Cardior's RNA-based therapeutics, particularly CDR132L, currently in Phase II clinical trials for treating heart failure. Cardior Pharmaceuticals is a Germany-based company that offers angiotensin-converting enzyme inhibitors.

Regional Outlook

North America was the largest region in the angina market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Angina Market?

The angina market consists of revenues earned by entities by providing treatments for stable angina, and microvascular angina. The market value includes the value of related goods sold by the service provider or included within the service offering. The angina market also includes sales of anticoagulants and statins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Angina Market Report 2026?

The angina market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the angina industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Angina Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $12.05 billion
Revenue Forecast In 2035 $14.84 billion
Growth Rate CAGR of 6.1% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Treatment, Drug Class, Application
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Angina Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Angina Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Angina Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Angina Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Adoption Of Combination Drug Therapies

4.2.2 Rising Use Of Long-Acting Nitrates

4.2.3 Growing Focus On Preventive Cardiac Care

4.2.4 Expansion Of Interventional Treatment Options

4.2.5 Enhanced Emphasis On Lifestyle And Risk Management

5. Angina Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Cardiology Clinics

5.3 Specialty Heart Centers

5.4 Retail Pharmacies

5.5 Online Pharmacies

6. Angina Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Angina Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Angina PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Angina Market Size, Comparisons And Growth Rate Analysis

7.3. Global Angina Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Angina Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Angina Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Angina Market Segmentation

9.1. Global Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

9.2. Global Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

9.3. Global Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

9.4. Global Angina Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinics, Hospitals, Other Applications

9.5. Global Angina Market, Sub-Segmentation Of Angina Pectoris, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

9.6. Global Angina Market, Sub-Segmentation Of Unstable Angina, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

9.7. Global Angina Market, Sub-Segmentation Of Prinzmetal Angina, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

9.8. Global Angina Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

10. Angina Market Regional And Country Analysis

10.1. Global Angina Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Angina Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Angina Market

11.1. Asia-Pacific Angina Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Angina Market

12.1. China Angina Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Angina Market

13.1. India Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Angina Market

14.1. Japan Angina Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Angina Market

15.1. Australia Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Angina Market

16.1. Indonesia Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Angina Market

17.1. South Korea Angina Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Angina Market

18.1. Taiwan Angina Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Angina Market

19.1. South East Asia Angina Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Angina Market

20.1. Western Europe Angina Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Angina Market

21.1. UK Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Angina Market

22.1. Germany Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Angina Market

23.1. France Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Angina Market

24.1. Italy Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Angina Market

25.1. Spain Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Angina Market

26.1. Eastern Europe Angina Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Angina Market

27.1. Russia Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Angina Market

28.1. North America Angina Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Angina Market

29.1. USA Angina Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Angina Market

30.1. Canada Angina Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Angina Market

31.1. South America Angina Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Angina Market

32.1. Brazil Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Angina Market

33.1. Middle East Angina Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Angina Market

34.1. Africa Angina Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Angina Market, Segmentation By Type, Segmentation By Treatment, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Angina Market Regulatory and Investment Landscape

36. Angina Market Competitive Landscape And Company Profiles

36.1. Angina Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Angina Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Angina Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Angina Market Other Major And Innovative Companies

Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc.

38. Global Angina Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Angina Market

40. Angina Market High Potential Countries, Segments and Strategies

40.1 Angina Market In 2030 - Countries Offering Most New Opportunities

40.2 Angina Market In 2030 - Segments Offering Most New Opportunities

40.3 Angina Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Angina Market, Overview Of Key Products - Product Examples
  • Table 2: Global Angina Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Angina Market, Supply Chain Analysis
  • Table 4: Global Angina Market, Major Raw Material Providers
  • Table 5: Global Angina Market, Major Resource Providers
  • Table 6: Global Angina Market, Major Manufacturers (Suppliers)
  • Table 7: Global Angina Market, Major Distributors And Channel Partners
  • Table 8: Global Angina Market, Key Technologies & Future Trends
  • Table 9: Global Angina Market, Major Trends
  • Table 10: Global Angina Market, Major End Users
  • Table 11: Global Angina Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Angina Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Angina Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Angina Market - TAM, US$ Billion, 2025
  • Table 15: Global Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Angina Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Angina Market, Sub-Segmentation Of Angina Pectoris, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Angina Market, Sub-Segmentation Of Unstable Angina, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Angina Market, Sub-Segmentation Of Prinzmetal Angina, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Angina Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Angina Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Angina Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Angina Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Angina Market - Company Scoring Matrix
  • Table 99: Pfizer Inc. Financial Performance
  • Table 100: Bayer AG Financial Performance
  • Table 101: AstraZeneca PLC Financial Performance
  • Table 102: Merck & Co Inc. Financial Performance
  • Table 103: Sanofi S.A. Financial Performance
  • Table 104: Global Angina Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Angina Market, Competitive Dashboard
  • Table 106: Global Angina Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Angina Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 108: Global, Angina Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 109: Global, Angina Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

List Of Figures

    Figure 1: Global Angina Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Angina Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Angina Market, Supply Chain Analysis
  • Figure 4: Global Angina Market, Major Raw Material Providers
  • Figure 5: Global Angina Market, Major Resource Providers
  • Figure 6: Global Angina Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Angina Market, Major Distributors And Channel Partners
  • Figure 8: Global Angina Market, Key Technologies & Future Trends
  • Figure 9: Global Angina Market, Major Trends
  • Figure 10: Global Angina Market, Major End Users
  • Figure 11: Global Angina Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Angina Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Angina Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Angina Market - TAM, US$ Billion, 2025
  • Figure 15: Global Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Angina Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Angina Market, Sub-Segmentation Of Angina Pectoris, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Angina Market, Sub-Segmentation Of Unstable Angina, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Angina Market, Sub-Segmentation Of Prinzmetal Angina, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Angina Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Angina Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Angina Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Angina Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Angina Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Angina Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Angina Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Angina Market - Company Scoring Matrix
  • Figure 99: Pfizer Inc. Financial Performance
  • Figure 100: Bayer AG Financial Performance
  • Figure 101: AstraZeneca PLC Financial Performance
  • Figure 102: Merck & Co Inc. Financial Performance
  • Figure 103: Sanofi S.A. Financial Performance
  • Figure 104: Global Angina Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Angina Market, Competitive Dashboard
  • Figure 106: Global Angina Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Angina Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 108: Global, Angina Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 109: Global, Angina Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

Read More About Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Angina Market Report 2026 - Global Outlook – By Type (Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types), By Treatment (Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Ot...

Angina Pectoris Drugs Market Report 2026 - Global Outlook – By Drugs (Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins), By Indication (Stable Angina...

Angina Pectoris Drugs Market Report 2026 - Global Outlook – By Drugs (Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins), By Indication (Stable Angina...

Angio Suites Market Report 2026 - Global Outlook – By Type (Single-Plane, Bi-Plane), By Technology (X-ray Angiography, Computed Tomography (CT) Angiography, Magnetic Resonance Angiography (MRA), Other Technologies), By A...

Coronary Artery Disease Market Report 2026 - Global Outlook – By Treatment (Medication, Surgery, Additional Therapy, Other Treatments), By Diagnosis (Electrocardiogram, Echocardiogram, Stress Test, Cardiac Catheterizatio...

Vascular Stent Market Report 2026 - Global Outlook – By Product (Coronary Stents, Peripheral Vascular Stents), By Material (Metallic Stents, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel), By Mode ...

Vascular Imaging Market Report 2026 - Global Outlook – By Technique (Magnetic Resonance Imaging, Ultrasound, Computed Tomography, Nuclear Imaging, X-Ray), By Procedure (Coronary Angiography, Peripheral Angiography, Neuro...

Hereditary Angioedema Therapeutics Market Report 2026 - Global Outlook – By Drug Class (C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Other Drug Classes), By Route of Administr...

Frequently Asked Questions

The Angina market was valued at $11.36 billion in 2025, increased to $12.05 billion in 2026, and is projected to reach $14.84 billion by 2030.

The global Angina market is expected to grow at a CAGR of 5.3% from 2026 to 2035 to reach $14.84 billion by 2035.

Some Key Players in the Angina market Include, Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol‑Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd .

Major trend in this market includes: Pharmaceutical Companies Innovate With Metoprolol Tartrate Tablets To Enhance Treatment For Coronary Artery Disease And Related Conditions. For further insights on this market. request a sample here

North America was the largest region in the angina market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us